The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Abstract
During the past decade, proof of the principle that peptide receptors can be used successfully for in vivo targeting of human cancers has been provided. The molecular basis for targeting rests on the in vitro observation that peptide receptors can be expressed in large quantities in certain tumors. The clinical impact is at the diagnostic level: in vivo receptor scintigraphy uses radiolabeled peptides for the localization of tumors and their metastases. It is also at the therapeutic level: peptide receptor radiotherapy of tumors emerges as a serious treatment option. Peptides linked to cytotoxic agents are also considered for therapeutic applications. The use of nonradiolabeled, noncytotoxic peptide analogs for long-term antiproliferative treatment of tumors appears promising for only a few tumor types, whereas the symptomatic treatment of neuroendocrine tumors by somatostatin analogs is clearly successful. The present review summarizes and critically evaluates the in vitro data on peptide and peptide receptor expression in human cancers. These data are considered to be the molecular basis for peptide receptor targeting of tumors. The paradigmatic peptide somatostatin and its receptors are extensively reviewed in the light of in vivo targeting of neuroendocrine tumors. The role of the more recently described targeting peptides vasoactive intestinal peptide, gastrin-releasing peptide, and cholecystokinin/gastrin is discussed. Other emerging and promising peptides and their respective receptors, including neurotensin, substance P, and neuropeptide Y, are introduced. This information relates to established and potential clinical applications in oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology of the Gastrointestinal Tract
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088394-3.x5000-4 · Cited by 4,597
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Self-citationThe Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami
Carraway, R., & Leeman, S. E. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43429-7 · Cited by 1,537
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., & Minna, J. D. (1985) · Nature · doi:10.1038/316823a0 · Cited by 1,349
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Self-citationPituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
Vaudry, D., Gonzalez, B. J., Basille, M., Yon, L., Fournier, A., & Vaudry, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01449-2 · Cited by 1,121
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T., & Westfall, T. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01352-8 · Cited by 896
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
LAMBERTS, S. W. J., KRENNING, E. P., & REUBI, J.-C. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 805
Self-citationHarmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., et al. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01360-7 · Cited by 765
Goldenberg, D. M., DeLand, F., Kim, E., Bennett, S., Primus, F. J., van Nagell, J. R., Estes, N., DeSimone, P., & Rayburn, P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806222982503 · Cited by 756
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Reubi, J., Waser, B., Schaer, J.-C., & Laissue, J. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100541 · Cited by 657
Self-citationMantyh, P. W., Rogers, S. D., Honore, P., Allen, B. J., Ghilardi, J. R., Li, J., Daughters, R. S., Lappi, D. A., Wiley, R. G., & Simone, D. A. (1997) · Science · doi:10.1126/science.278.5336.275 · Cited by 634
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Self-citationMolecular Biology of Somatostatin Receptors*
REISINE, T., & BELL, G. I. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-427 · Cited by 618
Reubi, J. C., & Waser, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1184-3 · Cited by 592
Self-citationClassification and nomenclature of somatostatin receptors
Hoyer, D., Bell, G. I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P. P. A., O'Carroll, A.-M., Patel, Y. C., Schonbrunn, A., Taylor, J. E., et al. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88988-9 · Cited by 570
Neurotensin and neurotensin receptors
Vincent, J.-P., Mazella, J., & Kitabgi, P. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01357-7 · Cited by 564
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
Expression cloning and characterization of the canine parietal cell gastrin receptor.
Kopin, A. S., Lee, Y. M., McBride, E. W., Miller, L. J., Lu, M., Lin, H. Y., Kolakowski, L. F., & Beinborn, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3605 · Cited by 508
Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder, R. V., & Reubi, J. C. (1999) · PubMed · Cited by 506
Self-citationTreatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
High Levels of Intracellular Bombesin Characterize Human Small-Cell Lung Carcinoma
Moody, T. W., Pert, C. B., Gazdar, A. F., Carney, D. N., & Minna, J. D. (1981) · Science · doi:10.1126/science.6272398 · Cited by 487
Receptor Endocytosis and Dendrite Reshaping in Spinal Neurons After Somatosensory Stimulation
Mantyh, P. W., DeMaster, E., Malhotra, A., Ghilardi, Rogers, S. D., Mantyh, C. R., Liu, H., Basbaum, A. I., Vigna, Maggio, J. E., et al. (1995) · Science · doi:10.1126/science.7539937 · Cited by 476
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Rohrer, S. P., Birzin, E. T., Mosley, R. T., Berk, S. C., Hutchins, S. M., Shen, D.-M., Xiong, Y., Hayes, E. C., Parmar, R. M., Foor, F., et al. (1998) · Science · doi:10.1126/science.282.5389.737 · Cited by 458
Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.
Wank, S. A., Pisegna, J. R., & de Weerth, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8691 · Cited by 446
Gibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Press, O. W., Appelbaum, F., Martin, P. J., Matthews, D. C., Bernstein, I. D., Eary, J. F., Nelp, W. B., Gooley, T., Glenn, S., Porter, B., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92225-3 · Cited by 428
Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1050-8 · Cited by 424
Yttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J. C., Poncelet, M., Gueudet, C., Héaulme, M., Leyris, R., & Brouard, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.65 · Cited by 417
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor
Mazella, J., Zsürger, N., Navarro, V., Chabry, J., Kaghad, M., Caput, D., Ferrara, P., Vita, N., Gully, D., Maffrand, J.-P., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26273 · Cited by 390
Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor
Pedrazzini, T., Seydoux, J., Künstner, P., Aubert, J.-F., Grouzmann, E., Beermann, F., & Brunner, H. R. (1998) · Nature Medicine · doi:10.1038/nm0698-722 · Cited by 389
Noble, F., Wank, S. A., Crawley, J. N., Bradwejn, J., Seroogy, K. B., Hamon, M., & Roques, B. P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01427-3 · Cited by 384
Reubi, J. C., Kvols, L. K., Waser, B., Nagorney, D. M., Heitz, P. U., Charboneau, J. W., Reading, C. C., & Moertel, C. G. (1990) · PubMed · Cited by 375
Self-citationThe first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
Rudolf, K., Eberlein, W., Engel, W., Wieland, H. A., Willim, K. D., Entzeroth, M., Wienen, W., Beck-Sickinger, A. G., & Doods, H. N. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90822-2 · Cited by 374
Endocytosis and recycling of G protein-coupled receptors
Koenig, J. A., & Edwardson, J. M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01091-2 · Cited by 357
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi, J. C., Schaer, J., & Waser, B. (1997) · PubMed · Cited by 349
Self-citationSubstance P: a pioneer amongst neuropeptides
Hökfelt, T., Pernow, B., & Wahren, J. (2001) · Journal of Internal Medicine · doi:10.1046/j.0954-6820.2000.00773.x · Cited by 346
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Peptide receptor imaging and therapy.
Kwekkeboom, D. J., Krenning, E. P., & de Jong, M. (2000) · PubMed · Cited by 330
Inagami, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94025-1 · Cited by 326
Homo- and Heterodimerization of Somatostatin Receptor Subtypes
Pfeiffer, M., Koch, T., Schröder, H., Klutzny, M., Kirscht, S., Kreienkamp, H., Höllt, V., & Schulz, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006084200 · Cited by 319
Villalba, M., Bockaert, J., & Journot, L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00083.1997 · Cited by 306
Somatostatin Analogs in Acromegaly
Freda, P. U. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3013 · Cited by 298
Di Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
Reubi, J. C., Läderach, U., Waser, B., Gebbers, J.-O., Robberecht, P., & Laissue, J. A. (2000) · PubMed · Cited by 287
Self-citationWada, E., Way, J., Shapira, H., Kusano, K., Lebacq-Verheyden, A. M., Coy, D., Jensen, R., & Battey, J. (1991) · Neuron · doi:10.1016/0896-6273(91)90250-4 · Cited by 286
Kumar, U., Sasi, R., Suresh, S., Patel, A., Thangaraju, M., Metrakos, P., Patel, S. C., & Patel, Y. C. (1999) · Diabetes · doi:10.2337/diabetes.48.1.77 · Cited by 284
Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study
Kouroumalis, E., Skordilis, P., Thermos, K., Vasilaki, A., Moschandrea, J., & Manousos, O. N. (1998) · Gut · doi:10.1136/gut.42.3.442 · Cited by 280
Vasoactive intestinal peptide: cardiovascular effects
Henning, R. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00229-7 · Cited by 280
Behr, T. M., Goldenberg, D. M., & Becker, W. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050216 · Cited by 274
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
Schally, A., & Nagy, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410001 · Cited by 271
Gut Peptides: Biochemistry and Physiology
Walsh, J. H., Dockray, G. J., & Mitty, R. D. (1994) · The Endocrinologist · doi:10.1097/00019616-199411000-00012 · Cited by 267
Henze, M., Schuhmacher, J., Hipp, P., Kowalski, J., Becker, D. W., Doll, J., Mäcke, H. R., Hofmann, M., Debus, J., & Haberkorn, U. (2001) · PubMed · Cited by 265
Effects of neuropeptide Y on the electrical properties of neurons
Colmers, W. F., & Bleakman, D. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90046-9 · Cited by 264
Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
Heppeler, A., Froidevaux, S., Eberle, A., & Maecke, H. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374516 · Cited by 258
Virgolini, I., Raderer, M., Kurtaran, A., Angelberger, P., Banyai, S., Yang, Q., Li, S., Banyai, M., Pidlich, J., Niederle, B., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311703 · Cited by 257
Spindel, E. R., Giladi, E., Brehm, P., Goodman, R. H., & Segerson, T. P. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1956 · Cited by 255
Hypothalamic Hormones and Cancer
Schally, A. V., Comaru-Schally, A. M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. L., & Halmos, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0217 · Cited by 254
Cellular biology of somatostatin receptors
Csaba, Z., & Dournaud, P. (2001) · Neuropeptides · doi:10.1054/npep.2001.0848 · Cited by 250
Gastrin-Releasing Peptide Receptors in Non-Neoplastic and Neoplastic Human Breast
Gugger, M., & Reubi, J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65525-3 · Cited by 248
Self-citationThe use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers
Emons, G., & Schally, A. V. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138714 · Cited by 244
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
Krenning, E. P., de Jong, M., Kooij, P. P. M., Breeman, W. A. P., Bakker, W. H., de Herder, W. W., van Eijck, C. H. J., Kwekkeboom, D. J., Jamar, F., Pauwels, S., et al. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s23 · Cited by 234
Dual pathways of internalization of the cholecystokinin receptor.
Roettger, B. F., Rentsch, R. U., Pinon, D., Holicky, E., Hadac, E., Larkin, J. M., & Miller, L. J. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1029 · Cited by 232
Somatostatin receptor subtype gene expression in pituitary adenomas
Miller, G. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1386 · Cited by 220
Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.
Siegrist, W., Solca, F., Stutz, S., Giuffrè, L., Carrel, S., Girard, J., & Eberlé, A. N. (1989) · PubMed · Cited by 220
Hypothalamic Hormones and Cancer
Treichel, J. A. (1982) · Science News · doi:10.2307/3966511 · Cited by 216
Shojamanesh, H., Gibril, F., Louie, A., Ojeaburu, J. V., Bashir, S., Abou‐Saif, A., & Jensen, R. T. (2002) · Cancer · doi:10.1002/cncr.10195 · Cited by 215
Neuropeptide Y Family of Hormones: Receptor Subtypes and Antagonists
Balasubramaniam, A. (1997) · Peptides · doi:10.1016/s0196-9781(96)00347-6 · Cited by 213
Expression of somatostatin receptor subtypes in human brain tumors
Dutour, A., Kumar, U., Panetta, R., Ouafik, L., Fina, F., Sasi, R., & Patel, Y. C. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980529)76:5<620::aid-ijc2>3.0.co;2-s · Cited by 211
Ulrich, C. D., Holtmann, M., & Miller, L. J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70491-3 · Cited by 209
Kulaksiz, H., Eissele, R., Rössler, D., Schulz, S., Höllt, V, Cetin, Y., & Arnold, R. (2002) · Gut · doi:10.1136/gut.50.1.52 · Cited by 209
Gastrin, CCK, Signaling, and Cancer
Rozengurt, E., & Walsh, J. H. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.49 · Cited by 209
Bagnato, A., Salani, D., Castro, V. D., et al. (1999) · PubMed · Cited by 207
Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization
Hennig, I. M., Laissue, J. A., Horisberger, U., & Reubi, J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610608 · Cited by 206
Self-citationTermanini, B., Gibril, F., Reynolds, J., Doppman, J., Chen, C., Stewart, C., Sutliff, V., & Jensen, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024287 · Cited by 206
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100490 · Cited by 206
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
Central nervous system pharmacology of neuropeptide Y
Wettstein, J. G., Earley, B., & Junien, J. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98598-k · Cited by 202
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail, L., Saint‐Laurent, N., Chastre, E., Vaillant, J., Gespach, C. P., Capellá, G., Kalthoff, H., Lluı́s, F., Vaysse, N., & Susini, C. (1996) · PubMed · Cited by 201
Fekete, M., Wittliff, J. L., & Schally, A. V. (1989) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860030302 · Cited by 200
Development of High Affinity Selective VIP1 Receptor Agonists
Gourlet, P., Vandermeers, A., Vertongen, P., Rathe, J., de Neef, P., Cnudde, J., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00228-3 · Cited by 200
Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.
Reubi, J. C. (1995) · PubMed · Cited by 198
Self-citation[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging
Nock, B., Nikolopoulou, A., Chiotellis, E., Loudos, G., Maintas, D., Reubi, J., & Maina, T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1040-x · Cited by 194
Self-citationCloning and Functional Expression of a Human Neuroendocrine Vasoactive Intestinal Peptide Receptor
Sreedharan, S. P., Patel, D. R., Huang, J. X., et al. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1658 · Cited by 193
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
Panetta, R., & Patel, Y. C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00956-2 · Cited by 185
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma
Reubi, J. C., Waser, B., Friess, H., Büchler, M., & Laissue, J. (1998) · Gut · doi:10.1136/gut.42.4.546 · Cited by 185
Self-citationBiologic and immunologic activities and applications of somatostatin analogs
Vale, W., Rivier, J., Ling, N., & Brown, M. (1978) · Metabolism · doi:10.1016/0026-0495(78)90081-1 · Cited by 184
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.398 · Cited by 180
Molecular biology of somatostatin receptors
Reisine, T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.427 · Cited by 179
Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current
Schweitzer, P., Madamba, S., & Siggins, G. R. (1990) · Nature · doi:10.1038/346464a0 · Cited by 173
Saveanu, A., Gunz, G., Dufour, H., Caron, P., Fina, F., Ouafik, L., Culler, M. D., Moreau, J. P., Enjalbert, A., & Jaquet, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7099 · Cited by 168
Grundker, C. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1427 · Cited by 168
Reile, H., Armatis, P. E., & Schally, A. V. (1994) · The Prostate · doi:10.1002/pros.2990250105 · Cited by 166
Gonadotropin-Releasing Hormone Binding Sites in Human Breast Carcinoma
Eidne, K. A., Flanagan, C. A., & Millar, R. P. (1985) · Science · doi:10.1126/science.2992093 · Cited by 166
Effects of Gastrin, Proglumide, and Somatostatin on Growth of Human Colon Cancer
Palmer Smith, J., & Solomon, T. E. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80075-1 · Cited by 166
Sonnenberg, G. E., Keller, U., Perruchoud, A., Burckhardt, D., & Gyr, K. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90015-9 · Cited by 164
Weckbecker, G., Briner, U., Lewis, I., & Bruns, C. (2002) · Endocrinology · doi:10.1210/en.2002-220219 · Cited by 163
HALMOS, G., ARENCIBIA, J. M., SCHALLY, A. V., DAVIS, R., & BOSTWICK, D. G. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67947-5 · Cited by 163
Mazella, J. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00130-3 · Cited by 160
Hellmich, M. R., Rui, X., Hellmich, H. L., Fleming, R., Evers, B. M., & Townsend, C. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005754200 · Cited by 154
The Tumor Biology Of Gastrin And Cholecystokinin
Rehfeld, J. F., & van Solinge, W. W. (1994) · Advances in cancer research · doi:10.1016/s0065-230x(08)60403-0 · Cited by 152
Gourlet, P., Vertongen, P., Vandermeers, A., Vandermeers‐Piret, M., Rathé, J., NEEF, P. D., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(96)00322-1 · Cited by 151
Schaer, J., Waser, B., Mengod, G., & Reubi, J. C. (1997) · International Journal of Cancer · Cited by 151
Self-citationReceptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cells
Göke, R., & Conlon, J. M. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1160357 · Cited by 147
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Bernard, B. F., Krenning, E. P., Breeman, W. A. P., et al. (1997) · PubMed · Cited by 146
Zitzer, H., Hönck, H., Bächner, D., Richter, D., & Kreienkamp, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32997 · Cited by 141
Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin
Ji, B., Bi, Y., Simeone, D. M., Mortensen, R. M., & Logsdon, C. D. (2001) · Gastroenterology · doi:10.1053/gast.2001.29557 · Cited by 140
Neuropeptides as Autocrine Growth Factors in Cancer Cells
Moody, T. W., Chan, D. C. F., Fahrenkrug, J., & Jensen, R. T. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391621 · Cited by 140
Nagalla, S. R., Barry, B. J., Creswick, K. E., Eden, P., Taylor, J. T., & Spindel, E. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6205 · Cited by 138
Reubi, J. C. (1995) · PubMed · Cited by 135
Self-citationAntitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers
Schally, A. V., Schally, A. V., & Redding, T. W. (1984) · Experimental Biology and Medicine · doi:10.3181/00379727-175-41797 · Cited by 134
Moriarty, P., Dimaline, R., Thompson, D. G., & Dockray, G. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00675-6 · Cited by 131
Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi, J. C., Chayvialle, J. A., Franc, B., Cohen, R., Calmettes, C., & Modigliani, E. (1991) · PubMed · Cited by 129
Self-citationGoetzl, E. J., Voice, J. K., Shen, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241503798 · Cited by 129
Reubi, J. C., & Waser, B. (1996) · International Journal of Cancer · Cited by 126
Self-citationA vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
Moody, T. W., Zia, F. Z., Draoui, M., Brenneman, D. E., Fridkin, M., Davidson, A., & Gozes, I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4345 · Cited by 126
Dournaud, P., Boudin, H., Schönbrunn, A., Tannenbaum, G. S., & Beaudet, A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-03-01056.1998 · Cited by 125
Binding properties of somatostatin receptor subtypes
Bruns, C., Raulf, F., Hoyer, D., Schloos, J., Lübbert, H., & Weckbecker, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90072-4 · Cited by 125
The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
Hejna, M., Schmidinger, M., & Raderer, M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf142 · Cited by 125
Sharma, K., & Srikant, C. B. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980413)76:2<259::aid-ijc14>3.0.co;2-7 · Cited by 124
Endocytosis and recycling of G protein-coupled receptors
Koenig, J., & Edwardson, J. M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90643-x · Cited by 124
BIIE0246, a potent and highly selective non‐peptide neuropeptide Y Y 2 receptor antagonist
Dumont, Y., Cadieux, A., Doods, H. N., Pheng, L. H., Abounader, R., Hamel, É., Jacques, D., Regoli, D. C., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703162 · Cited by 121
Benali, N. L., Cordelier, P., Calise, D., Pagès, P., Rochaix, P., Nagy, A., Estève, J., Pour, P. M., Schally, A. V., Vaysse, N., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130196697 · Cited by 120
Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
Frucht, H., Gazdar, A. F., Park, J. A., Oie, H. K., & Jensen, R. T. (1992) · PubMed · Cited by 118
Singh, P., Owlia, A., Espeijo, R., & Dai, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8429 · Cited by 117
Goetze, J. P., Nielsen, F. C., Burcharth, F., & Rehfeld, J. F. (2000) · Cancer · Cited by 116
A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy
Moll, S., Nickeleit, V., Mueller‐Brand, J., et al. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80135-9 · Cited by 115
Reubi, J. C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06946.x · Cited by 115
Self-citationRegulatory peptide receptors in human hepatocellular carcinomas
Reubi, J. C., Zimmermann, A., Jonas, S., Waser, B., Neuhaus, P., Läderach, U., & Wiedenmann, B. (1999) · Gut · doi:10.1136/gut.45.5.766 · Cited by 114
Self-citationImmunobiology of vasoactive intestinal peptide (VIP)
Pozo, D., Delgado, M., Martı́nez, C., Guerrero, J. M., Leceta, J., Gomariz, R. P., & Calvo, J. R. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01525-x · Cited by 113
de Herder, W. W., Krenning, E. P., Malchoff, C. D., Hofland, L. J., Reubi, J., Kwekkeboom, D. J., Oei, H. Y., Pols, H. A. P., Bruining, H. A., Nobels, F. R. E., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90059-0 · Cited by 113
Self-citationFrieß, H., Zhu, Z., Liard, V., Shi, X., Shrikhande, S. V., Wang, L., Lieb, K., Korc, M., Palma, C., Zimmermann, A., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000067499.57309.f6 · Cited by 112
Self-citationLocalization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach
Reubi, J., Waser, B., Läderach, U., Stettler, C., Friess, H., Halter, F., & Schmassmann, A. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70131-8 · Cited by 111
Self-citationGlucocorticoids Down-Regulate Somatostatin Receptors on Pituitary Cells in Culture*
Schönbrunn, A. (1982) · Endocrinology · doi:10.1210/endo-110-4-1147 · Cited by 109
Papotti, M. G., Croce, S., Bellò, M., Bongiovanni, M., Allìa, E., Schindler, M., & Bussolati, G. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100494 · Cited by 108
Irmer, G., Bürger, C., Müller, R., Ortmann, O., Peter, U., Kakar, S. S., Neill, J. D., Schulz, K. ‐., & Emons, G. (1995) · PubMed · Cited by 106
Somatostatin receptors in human prostate and prostate cancer.
Reubi, J. C., Waser, B., Schaer, J., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673428 · Cited by 106
Self-citationSingh, P., Velasco, M. A. D., Given, R. L., Varró, A., & Wang, T. C. (2000) · Gastroenterology · doi:10.1053/gast.2000.8527 · Cited by 106
Novel analogues of neuropeptide Y with a preference for the Y 1 ‐receptor
Söll, R., Dinger, M. C., Lundell, I., Larhammer, D., & Beck‐Sickinger, A. G. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02161.x · Cited by 103
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Visser, T. J., Kooij, P. P. M., van Gameren, A., & Krenning, E. P. (2001) · PubMed · Cited by 102
Antiangiogenic effects of somatostatin analogues
de la Torre, N. G., Wass, J. A. H., & Turner, H. E. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01619.x · Cited by 101
Gorn, A. H., Rudolph, S. M., Flannery, M. R., Morton, C. C., Weremowicz, S., Wang, T. Z., Krane, S. M., & Goldring, S. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117970 · Cited by 100
SST3-selective potent peptidic somatostatin receptor antagonists
Reubi, J. C., Schaer, J., Wenger, S., Hoeger, C. A., Érchegyi, J., Waser, B., & Rivier, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250483897 · Cited by 100
Self-citationReubi, J. C., Horisberger, U., Каппелер, А., et al. (1998) · Blood · doi:10.1182/blood.v92.1.191.413k12_191_197 · Cited by 100
Self-citationWeinberg, D. S., Ruggeri, B., Barber, M. T., Biswas, S. B., Miknyocki, S., & Waldman, S. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119570 · Cited by 99
Ahmed, S. I., Thompson, J., Coulson, J. M., & Woll, P. J. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.4.3795 · Cited by 99
Selby, J. B. (1996) · Clinical Nuclear Medicine · doi:10.1097/00003072-199602000-00028 · Cited by 99
Zia, H., Hida, T., Jakowlew, S. B., Birrer, M. J., Gozes, Y., Reubi, J. C., Fridkin, M., Gozes, I., & Moody, T. W. (1996) · PubMed · Cited by 97
Self-citationSchumacher, T., Höfer, S., Eichhorn, K., Wasner, M., Zimmerer, S., Freitag, P., Probst, A., Gratzl, O., Reubi, J. C., Maëcke, H. R., et al. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0717-x · Cited by 96
Self-citationReubi, J. C., & Waser, B. (1996) · International Journal of Cancer · Cited by 93
Self-citationEpelbaum, J., Bertherat, J. Y., Prevost, G. P., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D., & Plouin, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1837 · Cited by 92
A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors
Reubi, J. C., Eisenwiener, K., Rink, H., Waser, B., & Mäcke, H. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02651-1 · Cited by 91
Self-citationReubi, J. C., Mazzucchelli, L., & Laissue, J. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90754-4 · Cited by 89
Self-citationLebtahi, R., Cloirec, J. L., Houzard, C., Daou, D., Sobhani, I., Sassolas, G., Mignon, M., Bourguet, P., & Guludec, D. L. (2002) · PubMed · Cited by 89
Localization and characterization of neuropeptide receptors in human colon
Rettenbacher, M., & Reubi, J. C. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100454 · Cited by 89
Self-citationDevelopment of a selective agonist at the somatostatin receptor subtype sstr1.
Liapakis, G., Hoeger, C. A., Rivier, J., & Reisine, T. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12384-7 · Cited by 88
Growth factor and peptide receptors in small cell lung cancer
Moody, T. W., & Cuttitta, F. F. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90098-n · Cited by 88
Barreau, C., Dufresne, M., Clerc, P., Sanchez, D., Corominola, H., Moriscot, C., Guy‐Crotte, O., Escrieut, C., Vaysse, N., Gomis, R., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2015 · Cited by 88
Neuropeptide Y: a possible role in hypertension?
Michel, M. C., & Rascher, W. (1995) · PubMed · Cited by 87
Highly Potent Cyclic Disulfide Antagonists of Somatostatin
Hocart, S. J., Jain, R., Murphy, W. A., Taylor, J. E., & Coy, D. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806289 · Cited by 87
Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue
Reubi, J. C., Waser, B., Gugger, M., Frieß, H., Kleeff, J. H., Kayed, H., Büchler, M. W., & Laissue, J. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00697-8 · Cited by 87
Self-citationSomatostatin receptor imaging. the presence of somatostatin receptors in rheumatoid arthritis
Vanhagen, P. M., Markusse, H. M., Lamberts, S. W. J., Kwekkeboom, D. J., Reubi, J. C., & Krenning, E. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371017 · Cited by 87
Self-citationThe Calcitonin Gene Peptides: Biology and Clinical Relevance
Zaidi, M., Moonga, B. S., Bevis, P. J. R., Bascal, Z. A., & Breimer, L. H. (1990) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369009105900 · Cited by 87
Expression of Somatostatin Receptor Subtypes in Cultured Astrocytes and Gliomas
Held‐Feindt, J., Becker, I., Blömer, U., Hugo, H., Mehdorn, H. M., Krisch, B., & Mentlein, R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65051997.x · Cited by 86
Farra, C. D., Sarret, P., Navarro, V., Botto, J.-M., Mazella, J., & Vincent, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1225 · Cited by 85
Jensen, R. T. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00015 · Cited by 84
Ryder, N. M., Guha, S., Hines, O. J., Reber, H. A., & Rozengurt, E. (2000) · Journal of Cellular Physiology · Cited by 83
Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini, I. J., Szilvási, I., Kurtaran, A., Angelberger, P., Raderer, M., Havlik, E., Vorbeck, F., Bischof, C., Leimer, M., Dorner, G., et al. (1998) · PubMed · Cited by 83
Milovanović, S. R., Radulovic, S. S., Groot, K., & Schally, A. V. (1992) · The Prostate · doi:10.1002/pros.2990200403 · Cited by 82
Janson, E., Stridsberg, M., Gobl, A., Westlin, J.-E., & Öberg, K. (1998) · PubMed · Cited by 81
Effects of bombesin on growth of human small cell lung carcinoma in vivo
Alexander, R. W. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90344-9 · Cited by 81
Ding, W.-Q., Kuntz, S. M., & Miller, L. J. (2002) · PubMed · Cited by 80
Somatostatin receptor subtype gene expression in human endocrine gastroentero‐pancreatic tumours
Jais, P. H., Terris, B., Ruszniewski, P. B., Romancer, M. L., Reyl-Desmars, F., Vissuzaine, C., Cadiot, G., Mignon, M., & Lewin, M. J. M. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1740719.x · Cited by 78
Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors
Cassoni, P., Sapino, A., Stella, A., Fortunati, N., & Bussolati, G. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<695::aid-ijc6>3.0.co;2-q · Cited by 76
Augmented expression of endothelin‐1, endothelin‐3 and the endothelin‐B receptor in breast carcinoma
Alanen, Deng, & Chakrabarti, S. K. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00795.x · Cited by 75
Expression of five somatostatin receptor mRNAs in the human brain and pituitary
Thoss, V. S., P�rez, J., Probst, A., & Hoyer, D. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168430 · Cited by 75
Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft
Palma, C., Bigioni, M., Irrissuto, C., Nardelli, F., Maggi, C. A., & Manzini, S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0946 · Cited by 73
Pagotto, U., Arzberger, T., Hopfner, Ú., Sauer, J., Renner, U., NEWTON, C. J., Lange, M., Uhl, E., Weindl, A., & Stalla, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118249 · Cited by 73
Wang, Z. L., Bennet, W. M., Wang, R. M., Ghatei, M. A., & Bloom, S. R. (1994) · Endocrinology · doi:10.1210/endo.135.1.8013354 · Cited by 72
Zitzer, H., Richter, D., & Kreienkamp, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18153 · Cited by 71
Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells
Toi, M., Jones, C., & Kane, M. A. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00597-8 · Cited by 70
Jensen, R. T. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910611.x · Cited by 70
Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function
Sheikh, S. P. (1991) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1991.261.5.g701 · Cited by 69
Sethi, T., Herget, T., Wu, S., Walsh, J. H., & Rozengurt, E. (1993) · PubMed · Cited by 69
Michel, M. C., & Rascher, W. (1995) · Journal of Hypertension · doi:10.1097/00004872-199504000-00003 · Cited by 69
Fehmann, H. C., Hering, B. J., Wolf, M.-J., Brandhorst, H., Brandhorst, D., Bretzel, R. G., Federlin, K., & Göke, B. (1995) · Pancreas · doi:10.1097/00006676-199508000-00014 · Cited by 67
Behr, T. M., Memtsoudis, S. G., Sharkey, R. M., Blumenthal, R. D., Dunn, R. M., Gratz, S., Wieland, E., Nebendahl, K., Schmidberger, H., Goldenberg, D. M., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<787::aid-ijc19>3.0.co;2-z · Cited by 66
Cited by
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Wadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 924
Imhof, A., Brunner, P., Marincek, N., Briel, M., Schindler, C., Rasch, H., Mäcke, H. R., Rochlitz, C., Müller-Brand, J., & Walter, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7873 · Cited by 641
Metadata
- Authors
- Reubi, J. C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 389-427
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2045681528
- Cited by
- 1,131
- References
- 249
- FWCI
- 29.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.